Takeda Pharmaceutical Company Limited Is A Global Biopharmaceutical Leader With A Rich History Dating Back To 1781. Founded In Osaka, Japan, Takeda Has Transitioned From Traditional Herbal Medicine To A Focus On Innovative Therapies, Rare Disease Treatments, And Vaccines. The Company Operates In Over 80 Countries And Emphasizes Areas Such As Oncology, Rare Diseases, Neuroscience, Gastroenterology, Plasma-Derived Therapies, And Vaccines.Takeda Offers A Range Of Therapeutic Solutions, Including Treatments For Genetic Disorders, Targeted Therapies For Cancers, And Biologics For Inflammatory Bowel Diseases. Notable Products Include Entyvioâ® For Ulcerative Colitis, Ninlaroâ® For Multiple Myeloma, And Gammagard Liquidâ® For Primary Immunodeficiency. The Company Is Committed To A Patient-Centric Approach, Aiming To Address Unmet Medical Needs While Promoting Integrity And Sustainability In Its Operations.
